StartUp Health community member CraniUS is a neurotechnology company developing an implantable platform to bypass the blood-brain barrier for long-term, programmable drug delivery. Other funding this week included massive global rounds across AI infrastructure, women’s health, insurance, clinical trials, and diagnostic tools, underscoring continued investor momentum worldwide.
Feb 3, 2026
•
8 min read
CraniUS, a Baltimore, MD-based neurotechnology company in the StartUp Health Alzheimer’s & Brain Health Moonshot Community, raised $20M in Series B funding. The raise included $19M from private investors and $1M in non-dilutive funding from the State of Maryland, bringing the company’s total capital raised to approximately $40M. <source>
Other reported global health innovation funding this week included:
Free stories, podcasts & videos from the StartUp Health community direct to your inbox